Orion Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Orion Pharma has a total shareholder equity of BDT23.3B and total debt of BDT22.3B, which brings its debt-to-equity ratio to 95.8%. Its total assets and total liabilities are BDT52.3B and BDT29.0B respectively. Orion Pharma's EBIT is BDT686.0M making its interest coverage ratio 4.7. It has cash and short-term investments of BDT250.9M.
Key information
95.8%
Debt to equity ratio
৳22.32b
Debt
Interest coverage ratio | 4.7x |
Cash | ৳250.87m |
Equity | ৳23.29b |
Total liabilities | ৳29.03b |
Total assets | ৳52.32b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ORIONPHARM's short term assets (BDT16.2B) exceed its short term liabilities (BDT8.7B).
Long Term Liabilities: ORIONPHARM's short term assets (BDT16.2B) do not cover its long term liabilities (BDT20.3B).
Debt to Equity History and Analysis
Debt Level: ORIONPHARM's net debt to equity ratio (94.7%) is considered high.
Reducing Debt: ORIONPHARM's debt to equity ratio has increased from 44.1% to 95.8% over the past 5 years.
Debt Coverage: ORIONPHARM's debt is not well covered by operating cash flow (7.2%).
Interest Coverage: ORIONPHARM's interest payments on its debt are well covered by EBIT (4.7x coverage).